Dr. Graham D. Sher, MB BCh, PhD, FRCP(C), ICD.D, O.C. is a Creative Testing Solutions board member. Dr. Sher is the Chief Executive Officer of Canadian Blood Services, the agency charged with managing Canada's national blood, plasma, stem cell, and organs and tissues programs in all provinces and territories across Canada, excluding Quebec. He has been with Canadian Blood Services (CBS) since its beginning, when he joined as its first Vice President of Medical, Scientific & Clinical Management in 1998. As Chief Executive Officer Dr. Sher (since 2001), Dr. Sher is leading CBS through an extensive, multiyear transformation journey, including product and service offerings diversification, innovation and knowledge creation, and a relentless focus on business excellence and value creation. Dr. Sher is a recognized expert in transfusion medicine and science, is widely published in this field and regularly sought after as a speaker worldwide.
He sits on several blood system and health care related advisory bodies and consults with other countries as they transform their blood systems. Dr. Sher is a founding member and the current Chair of the Alliance of Blood Operators. He was the first international director on the AABB Board and served as its president from 2013-14. He served on the Canadian Partnership Against Cancer (CPAC) board from 2012-22, serving as chair from 2016-22. He also sits on the C.D. Howe Institute’s Health Policy Council.
Dr. Sher has a passion for health system design, management and governance, transformation, and performance improvement. He has also achieved Director’s Certification from the Institute of Corporate Directors.
In September 2015, Dr. Sher was named as one of the 20 most powerful physicians and medical leaders in Canada. He received the AABB President’s award in 2018 and again in 2022. Dr. Sher was appointed as an Officer of the Order of Canada in December 2021 and was awarded an honorary Doctor of Laws (LL.D.) (honoris causa) from the University of Manitoba’s Max Rady College of Medicine in May 2024.
Dr. Sher’s expertise in international blood and health care systems is invaluable to CTS as we uphold the highest quality in testing services for whole blood and source plasma organizations.